FMP
Insulet Corporation
PODD
NASDAQ
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
166.19 USD
2.02 (1.22%)
About
ceo
Dr. James R. Hollingshead Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.insulet.com
exchange
NASDAQ
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
CIK
0001145197
ISIN
US45784P1012
CUSIP
45784P101
Address
100 Nagog Park
Phone
978 600 7000
Country
US
Employee
3,000
IPO Date
May 15, 2007
Key Executives
